Type 8-Okay 23andMe Holding Co. To: Aug 13

About 23andMe

23andMe, headquartered in Sunnyvale, Calif., Is a number one client genetics and analysis firm. Based in 2006, the corporate’s mission is to assist folks entry, perceive and profit from the human genome. 23andMe pioneered direct entry to genetic data as the one firm with a number of FDA clearances for genetic well being threat reporting. The corporate has created the world’s largest crowdsourcing platform for genetic analysis, with round 80 % of its shoppers selecting to take part. The 23andMe analysis platform has generated greater than 180 publications on the genetic underpinnings of a variety of ailments, situations and traits. The platform additionally powers the 23andMe Therapeutics group, which is at the moment pursuing drug discovery applications rooted in human genetics in a variety of pathological areas, together with oncology, respiratory and heart problems, along with different areas. therapeutic. Extra data is out there at www.23andMe.com.

Ahead-looking statements

This press launch incorporates forward-looking statements throughout the which means of Part 27A of the Securities Act of 1933, as amended, and Part 21E of the Securities Alternate Act of 1934, as amended, together with statements relating to future efficiency. 23andMe actions? in genetics and therapeutics for most of the people and the expansion and potential of its unique analysis platform. All statements, apart from statements of historic truth, included or included on this press launch, together with statements relating to technique, monetary situation, financing of continuous operations, money reserves, projected prices, the plans and goals of the administration of 23andMe, are forward-looking. forward-looking statements. The phrases ?? consider, ??? ?? anticipate, ??? ?? estimates, ?? ??plans,?? ?? waits, ??? ?? for, ??? ??might,?? ?? might, ?? ??ought to,?? ??potential,?? ??seemingly,?? ??tasks,?? ?? Keep on, ?? ??might be,?? ??program,?? and ?? can be ?? or, in every case, their destructive or different variations or comparable terminology, are supposed to establish forward-looking statements, though not all forward-looking statements comprise these figuring out phrases. These forward-looking statements are predictions based mostly on 23andMe’s present expectations and projections relating to future occasions and varied assumptions. 23andMe can’t assure that it’s going to truly perform the plans, intentions or expectations disclosed in its forward-looking statements and you shouldn’t place undue reliance on 23andMe’s forward-looking statements. These forward-looking statements contain a variety of dangers, uncertainties (lots of that are past 23andMe’s management) or different assumptions that will trigger precise outcomes or efficiency to vary materially from these expressed or implied by such forward-looking statements. All forward-looking statements included on this press launch are made as of the date hereof and are expressly certified of their entirety by this warning, together with, with out limitation, the dangers and uncertainties described within the present report on the 23andMe type. 8-Okay filed on June 21, 2021, together with the audited consolidated monetary statements of 23andMe as at March 31, 2021 and 2020 filed as Exhibit 99.1 thereof and the MD&A and evaluation of economic situation and outcomes of operations included therein, and in any other case within the Firm’s Filings and Studies filed with the Securities and Alternate Fee. Besides as required by legislation, 23andMe assumes no obligation to replace or revise forward-looking statements, whether or not because of new data, future occasions or in any other case.

About Edith J.

Check Also

Harte Gold Proclaims Profitable Bidder in Sale and Funding Solicitation Course of

TORONTO, January 20, 2022 /CNW/ – As introduced on December 7, 2021HARTE GOLD CORP. (“Harte …